AstraZeneca PLC (AZN)
71.43
+0.01
(+0.01%)
USD |
NASDAQ |
Nov 04, 16:00
71.43
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Market Cap: 221.47B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 221.44B |
| October 31, 2024 | 220.60B |
| October 30, 2024 | 225.81B |
| October 29, 2024 | 233.22B |
| October 28, 2024 | 235.67B |
| October 25, 2024 | 232.70B |
| October 24, 2024 | 235.33B |
| October 23, 2024 | 238.59B |
| October 22, 2024 | 239.73B |
| October 21, 2024 | 240.11B |
| October 18, 2024 | 242.65B |
| October 17, 2024 | 241.90B |
| October 16, 2024 | 242.80B |
| October 15, 2024 | 241.38B |
| October 14, 2024 | 242.15B |
| October 11, 2024 | 239.83B |
| October 10, 2024 | 238.34B |
| October 09, 2024 | 240.31B |
| October 08, 2024 | 238.34B |
| October 07, 2024 | 238.34B |
| October 04, 2024 | 240.20B |
| October 03, 2024 | 241.62B |
| October 02, 2024 | 246.74B |
| October 01, 2024 | 243.92B |
| September 30, 2024 | 241.56B |
| Date | Value |
|---|---|
| September 27, 2024 | 240.66B |
| September 26, 2024 | 242.40B |
| September 25, 2024 | 240.42B |
| September 24, 2024 | 238.34B |
| September 23, 2024 | 239.18B |
| September 20, 2024 | 243.02B |
| September 19, 2024 | 244.63B |
| September 18, 2024 | 243.64B |
| September 17, 2024 | 243.49B |
| September 16, 2024 | 245.07B |
| September 13, 2024 | 242.68B |
| September 12, 2024 | 244.82B |
| September 11, 2024 | 249.69B |
| September 10, 2024 | 251.64B |
| September 09, 2024 | 250.80B |
| September 06, 2024 | 257.50B |
| September 05, 2024 | 257.34B |
| September 04, 2024 | 265.87B |
| September 03, 2024 | 265.78B |
| August 30, 2024 | 271.67B |
| August 29, 2024 | 270.68B |
| August 28, 2024 | 270.86B |
| August 27, 2024 | 270.40B |
| August 26, 2024 | 268.57B |
| August 23, 2024 | 268.69B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
99.18B
Minimum
Mar 16 2020
271.67B
Maximum
Aug 30 2024
183.26B
Average
190.07B
Median
Market Cap Benchmarks
| Amgen Inc | 170.35B |
| GSK PLC | 75.45B |
| Johnson & Johnson | 380.96B |
| Sanofi SA | 132.70B |
| TC BioPharm (Holdings) PLC | 0.6923M |
Market Cap Related Metrics
| PE Ratio | 34.51 |
| PS Ratio | 4.542 |
| PEG Ratio | 7.592 |
| Price to Book Value | 5.605 |
| Price to Free Cash Flow | 32.03 |
| Price | 71.43 |
| Earnings Yield | 2.90% |
| PEGY Ratio | 5.209 |
| Operating PE Ratio | 22.73 |
| Normalized PE Ratio | 31.63 |